Cargando…
Proteomic profiling of urine for the detection of colon cancer
BACKGROUND: Colorectal cancer is the second most common cause of cancer related death in the developed world. To date, no blood or stool biomarkers with both high sensitivity and specificity for potentially curable early stage disease have been validated for clinical use. SELDI and MALDI profiling a...
Autores principales: | Ward, Douglas G, Nyangoma, Stephen, Joy, Howard, Hamilton, Emma, Wei, Wenbin, Tselepis, Chris, Steven, Neil, Wakelam, Michael JO, Johnson, Philip J, Ismail, Tariq, Martin, Ashley |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440369/ https://www.ncbi.nlm.nih.gov/pubmed/18558005 http://dx.doi.org/10.1186/1477-5956-6-19 |
Ejemplares similares
-
Identification of serum biomarkers for colon cancer by proteomic analysis
por: Ward, D G, et al.
Publicado: (2006) -
SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard
por: Ward, Douglas G, et al.
Publicado: (2008) -
Urine Proteomics in the Era of Mass Spectrometry
por: Beasley-Green, Ashley
Publicado: (2016) -
Proteomics analysis of colon cancer progression
por: Saleem, Saira, et al.
Publicado: (2019) -
A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer
por: Ryan, Angela V, et al.
Publicado: (2006)